Reportable Segments (Tables)

9 Months Ended

Sep. 30, 2012

Schedule of Segment Reporting Information, by Segment

Company’s reportable segments and its corporate headquarters is presented below:



	Three Months Ended September 30, 2012
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales	$	82,968	$	117,752	$	53,529	$	—		$	254,249
Operating income (loss)	17,057		19,948		7,051		(12,024		)	32,032



	Nine Months Ended September 30, 2012
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales	$	228,921	$	336,278	$	145,095	$	—		$	710,294
Operating income (loss)	44,785		54,447		25,498		(35,754		)	88,976



	Three Months Ended September 30, 2011
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales	$	57,777	$	100,911	$	52,623	$	—		$	211,311
Operating income (loss)	12,584		16,109		8,548		(8,198		)	29,043



	Nine Months Ended September 30, 2011
	Energy & Chemicals		Distribution & Storage		BioMedical		Corporate			Total
Sales	$	149,414	$	275,966	$	149,570	$	—		$	574,950
Operating income (loss)	21,941		44,731		24,218		(26,051		)	64,839



	September 30, 2012		December 31, 2011
Assets:
Energy & Chemicals	$	237,381	$	203,067
Distribution & Storage	580,284		556,688
BioMedical	456,384		226,729
Corporate	49,187		187,991
Total Assets	$	1,323,236	$	1,174,475

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details